Senior insider sale
Chief Medical Officer at DYNE THERAPEUTICS, INC. — senior position signals high conviction
$80.5K
3.33K shares
What this filing means
KERR DOUGLAS plans to sell 3.33K shares of DYNE THERAPEUTICS, INC. valued at approximately $80.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/13/2026ACC: 0001972481-26-000258
Officer· Chief Medical Officer
Since Mar 2026
3.33K
Shares to sell
$80.5K
Approx. market value
8.31K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months2
Restricted Stock Units
Equity Compensation
8/12/2026
5.31KRestricted Stock Units
Equity Compensation
6/5/2026
3KTotal acquired8.31K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/12/2026 | Restricted Stock Units Equity Compensation | 5.31K | — |
6/5/2026 | Restricted Stock Units Equity Compensation | 3K | — |
| Total | 8.31K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
887.00
Market value
$16.3K
6/16/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
2.44K
Market value
$64.2K
8/13/2026
Total
Units
3.33K
Value
$80.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/16/2026 | 887.00 | $16.3K | — | Completed |
| Planned — Approximate Date | ||||
8/13/2026 | 2.44K | $64.2K | Nasdaq | Planned |
| Total | 3.33K | $80.5K | ||